Hayashi Hisao, Yano Motoyoshi, Fujita Yoshikazu, Wakusawa Shinya
Department of Medicine, Asanogawa General Hospital, Kanazawa, Japan.
Med Mol Morphol. 2006 Sep;39(3):121-6. doi: 10.1007/s00795-006-0326-7.
This review of the copper-iron interaction in Wilson's disease was mainly based on ten patients (three females and seven males) studied in our institutes because the genetic tests of ATP7B for Wilson's disease of primary copper toxicosis and HFE for hemochromatosis, the biochemical parameters of copper and iron, and morphological studies on biopsied liver specimens were complete. All patients had hypoceruloplasminemia and hepatic lesions compatible with Wilson's disease. One patient was homozygous and nine patients were compound heterozygous for the mutations in ATP7B, and all patients were free from the major mutation, C282Y, of HFE. The biochemical parameters of iron metabolism were not specific, except for serum ferritin concentration. Judging from the traditional criteria, seven patients had hyperferritinemia. Histochemical iron was stained in the livers of seven patients and histochemical copper was found in nine patients. Microanalysis was more sensitive than histochemistry, detecting copper and iron accumulation in the hepatocellular lipofuscin particles of all patients. Using an improved fixative, intralipofuscin distribution was found to be different between cuprothionein and iron complexes. Iron overload in Wilson's disease might be worsened after treatment because of the close relation to hypoceruloplasminemia, in which the iron efflux from the liver to the circulation is disturbed.
本关于威尔逊病中铜铁相互作用的综述主要基于在我们研究所研究的10名患者(3名女性和7名男性),因为对原发性铜中毒威尔逊病的ATP7B基因检测以及对血色素沉着症的HFE基因检测、铜和铁的生化参数以及对活检肝标本的形态学研究均完整。所有患者均有低铜蓝蛋白血症和与威尔逊病相符的肝脏病变。1名患者为ATP7B突变纯合子,9名患者为复合杂合子,且所有患者均无HFE的主要突变C282Y。除血清铁蛋白浓度外,铁代谢的生化参数并无特异性。根据传统标准,7名患者有高铁蛋白血症。7名患者肝脏有组织化学铁染色,9名患者有组织化学铜染色。微量分析比组织化学更敏感,检测到所有患者肝细胞脂褐素颗粒中有铜和铁蓄积。使用改良固定剂后,发现铜硫蛋白和铁复合物的脂褐素内部分布不同。由于与低铜蓝蛋白血症密切相关,威尔逊病中的铁过载在治疗后可能会加重,其中肝脏向循环系统的铁外流受到干扰。